Sartorius Stedim Biotech Stock

Equities

DIM

FR0013154002

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris 11:35:04 2024-06-17 EDT Pre-market 01:52:35
172 EUR -3.78% Intraday chart for Sartorius Stedim Biotech 173.1 +0.64%

Financials

Sales 2024 * 2.94B 3.15B 4.32B Sales 2025 * 3.33B 3.57B 4.9B Capitalization 16.74B 17.95B 24.65B
Net income 2024 * 335M 359M 493M Net income 2025 * 451M 484M 664M EV / Sales 2024 * 6.47 x
Net Debt 2024 * 2.27B 2.43B 3.34B Net Debt 2025 * 2.16B 2.32B 3.18B EV / Sales 2025 * 5.68 x
P/E ratio 2024 *
48.4 x
P/E ratio 2025 *
34.8 x
Employees 10,493
Yield 2024 *
0.43%
Yield 2025 *
0.63%
Free-Float 31.97%
More Fundamentals * Assessed data
Dynamic Chart
1 day-3.78%
1 week-7.25%
Current month-5.83%
1 month-12.60%
3 months-36.88%
6 months-25.57%
Current year-28.18%
More quotes
1 week
172.00
Extreme 172
190.35
1 month
172.00
Extreme 172
200.30
Current year
172.00
Extreme 172
281.00
1 year
160.55
Extreme 160.55
287.80
3 years
160.55
Extreme 160.55
551.00
5 years
120.60
Extreme 120.6
551.00
10 years
20.00
Extreme 20
551.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 19-03-25
Chairman 59 07-06-28
Chief Tech/Sci/R&D Officer 59 09-04-28
Members of the board TitleAgeSince
Director/Board Member 62 07-06-28
Chairman 59 07-06-28
Director/Board Member 67 15-04-06
More insiders
Date Price Change Volume
24-06-17 172 -3.78% 90,061
24-06-14 178.8 -0.69% 76,936
24-06-13 180 -1.21% 62,533
24-06-12 182.2 -3.95% 98,019
24-06-11 189.7 +2.29% 93,170

Real-time Euronext Paris, June 17, 2024 at 11:35 am

More quotes
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
172 EUR
Average target price
248.8 EUR
Spread / Average Target
+44.67%
Consensus